FAI Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
FAI Advisors's LLY Position: Q3 2026 in Review
FAI Advisors increased its Eli Lilly (LLY) stake by 5.8% in Q3 2026, buying an estimated $74.3K and bringing the position to 1,149 shares worth $1.33M. The position accounts for 0.52% of the portfolio, ranked #40.
FAI Advisors first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. 2,004 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- FAI Advisors held 1,149 shares of Eli Lilly worth $1.33M as of Q3 2026.
- FAI Advisors bought 63 Eli Lilly shares in Q3 2026, an estimated $74.3K.
- Eli Lilly made up 0.52% of FAI Advisors's portfolio in Q3 2026, its #40 holding.
- FAI Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
- 2,004 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on FAI Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.